Premium Information is available for this item - Upgrade for $1 a day
6505-01-092-4407
Usp Methotrexate Sodium For Injection
6505010924407 010924407 MEXATE MEXATE INJECTION NDC00015-3051-97
INC: 45604 Methotrexate Sodium For Injection
January 2023
6
Marketplace 6505-01-092-4407
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-092-4407 5+ Documents (More...)
6505-01-092-4407 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-092-4407
RQST Updated Every Day 6505-01-092-4407 RQST NE Related Documents 6505-01-092-4407 5+ Documents
6505-01-252-5601 Injection 270064322 https /fsc- https //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-092-4407
Methotrexate Sodium For Injection 270064322 6505-01-252-5601 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-092-4407
Usp Methotrexate Sodium For Injection Injection 270064322 /fsg-65/fsc-6505/us 6505-01-092-4407
https//www.nsnlookup.com Injection 6505-27-006-4321 Sodium For Injection -6505/us 6505-01-092-4407 https
Injection 270064322 Sodium For Injection 6505 -01-252-5601 6505-01-092-4407 For Injection 270064322
Sodium For Injection 6505-27-006- 4322 Methotrexate https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-092-4407
Usp Methotrexate Sodium For Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-092-4407 https
For Injection -4321 6505-33-190-5899 6505-01-301-8867 https// https//www.nsnlookup.com 6505/us 6505-01-092-4407
Restrictions 6505-01-092-4407
6505-01-092-4407 is a Usp Methotrexate Sodium For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-092-4407
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-092-4407
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-092-4407
- Part Number
- Manufacturer
- Status
- NDC00015-3051-97
- Manufacturer
- 29398 - Mead Johnson & Company, Llc (Active)
- Primary Buy
- Primary Buy
- MEXATE
- 29398 - Mead Johnson & Company, Llc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- MEXATE INJECTION
- 29398 - Mead Johnson & Company, Llc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-092-4407
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- Equivalent To 50.000 Milligrams Methotrexate Active Ingredient
- Physical Form [AGXW]
- Powder
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- Powder Equivalent To 50.000 Milligrams Methotrexate
- Total Primary Container Quantity [CSCW]
- 10
- Special Features [FEAT]
- 15 Ml Size Vial; Note: D
- Protective Storage Feature [AJCN]
- Antineoplastic Drug
- Supplementary Features [SUPP]
- Medsep Item For Dod,Bristol-Myers
Management Data 6505-01-092-4407
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- May 1989
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 10 Ea
- 00000000010EA
- K
Similar Supply Items to 6505-01-092-4407
Freight Information 6505-01-092-4407
6505-01-092-4407 has freight characteristics.. 6505-01-092-4407 has a variance between NMFC and UFC when transported by rail and the description should be consulted.